Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Immunosuppression in IgA Nephropathy

NCT03468972 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT03468972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03468972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Immunosuppression in IgA Nephropathy
Lead sponsor
Yonsei University
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2019
Completion date
May 31, 2023
Enrollment
174 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biopsy-proven iga nephropathy